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Abstract
This work investigated the ability of co-cultures of articular chondrocytes and mesenchymal stem
cells (MSCs) to repair articular cartilage in osteochondral defects. Bovine articular chondrocytes
and rat MSCs were seeded in isolation or in co-culture onto electrospun poly(ε-caprolactone)
(PCL) scaffolds and implanted into an osteochondral defect in the trochlear groove of 12-week old
Lewis rats. Additionally, a blank PCL scaffold and untreated defect were investigated. After 12
weeks, the extent of cartilage repair was analyzed through histological analysis, and the extent of
bone healing was assessed by quantifying the total volume of mineralized bone in the defect
through microcomputed tomography. Histological analysis revealed that the articular
chondrocytes and co-cultures led to repair tissue that consisted of more hyaline-like cartilage
tissue that was thicker and possessed more intense Safranin O staining. The MSC, blank PCL
scaffolds, and empty treatment groups generally led to the formation of fibrocartilage repair tissue.
Microcomputed tomography revealed that while there was an equivalent amount of mineralized
bone formation in the MSC, blank PCL, and empty treatment groups, the defects treated with
chondrocytes or co-cultures had negligible mineralized bone formation. Overall, even with a
reduced number of chondrocytes, co-cultures led to an equal level of cartilage repair compared to
the chondrocyte samples, thus demonstrating the potential for the use of co-cultures of articular
chondrocytes and MSCs for the in vivo repair of cartilage defects.
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Introduction
While a number of treatment options currently exist for the repair of articular cartilage
defects, these options primarily lead to short-term functional repair, but are not capable of
achieving stable, long-term repair of the tissue [1, 2]. Autologous chondrocyte implantation
(ACI) is generally one of the most often-used procedures for the treatment of cartilage
defects, and has been shown to have some success in repairing the damaged tissue [1, 3].
However, the isolation of appropriate numbers of autologous chondrocytes is not without
challenges. Chondrocytes are present in relatively low densities in native articular cartilage
[4], and the isolation of sufficient numbers would lead to large donor site morbidity [5].
Furthermore, the in vitro expansion of chondrocytes is associated with a rapid
dedifferentiation of the cells into a more fibroblastic phenotype, which ultimately leads to
the production inferior tissue [6]. Thus, numerous approaches have been investigated in
order to enhance the chondrogenic phenotype of expanded cells or to reduce the demand for
chondrocytes in the treatment of articular cartilage defects [7].
Co-cultures of articular chondrocytes and mesenchymal stem cells (MSCs) are one approach
that has been proposed to reduce the demand for articular chondrocytes and thus improve
articular cartilage treatments [8–11]. When co-cultured with MSCs, articular chondrocytes
have been observed to undergo enhanced proliferation and matrix production [9, 12–14].
This effect, which has been shown to be independent of MSC source or culture condition
[15], would allow for the use of reduced numbers of chondrocytes to achieve an equal
chondrogenic outcome [11]. Furthermore, the co-cultured cell population has been
demonstrated to be more sensitive to chondrogenic stimuli, such as transforming growth
factor-β3 (TGF-β3), and to produce a phenotype that is more stable after the removal of the
stimuli, compared to monocultures of either cell type [8]. While the beneficial effects of
MSCs on chondrocytes are crucial to the performance of these co-cultures, chondrocytes
have similarly been demonstrated to have beneficial effects on MSCs, which mitigates some
disadvantages associated with MSC chondrogenesis. The chondrogenesis of MSCs is
challenged by the eventual hypertrophy and mineralization of these cells after extended
culture in chondrogenic conditions [16]. However, co-culture with articular chondrocytes
has been demonstrated to reduce the hypertrophy of MSCs in culture [10, 17, 18]. Thus, the
advantages of co-cultures of articular chondrocytes and MSCs for the in vitro generation of
articular cartilage is well-documented; however the use of this cell population for in vivo
repair of articular cartilage defects has not been investigated.
The objective of the present study was to investigate the use of co-cultures of articular
chondrocytes and bone marrow-derived MSCs for the in vivo repair of articular cartilage in a
rat osteochondral defect. We hypothesized that the use of co-cultures of chondrocytes and
MSCs would lead to equal or greater cartilage repair compared to chondrocytes alone, thus
allowing for the use of reduced numbers of chondrocytes. Therefore, we implanted
electrospun poly(ε-caprolactone) (PCL) scaffolds, seeded with MSCs, chondrocytes, or co-
cultures of chondrocytes and MSCs into the trochlear groove of rats and evaluated the tissue
repair via histology and microcomputed tomography.
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Methods
Study design
The groups investigated in this study are outlined in Table 1. Briefly, bovine articular
chondrocytes and rat bone marrow-derived MSCs were seeded onto electrospun PCL
scaffolds to create three separate experimental groups. The AC group consisted of articular
chondrocytes seeded in monoculture at a density of 40,000 cells per scaffold; the MSC
group consisted of MSCs seeded in monoculture at a density of 40,000 cells per scaffold.
The CC group consisted of articular chondrocytes and MSCs seeded in a 1:3 ratio at a
density of 40,000 cells per scaffold (i.e. 10,000 chondrocytes and 30,000 MSCs).
Additionally, an empty control (empty) and a material control (PCL) were also investigated.
All samples (n=8 per group) were implanted into defects created in the trochlear groove of
Lewis rats for 12 weeks. Samples were analyzed for cartilage tissue formation through
histological scoring and for the formation of mineralized bone through microcomputed
tomography.
Scaffold fabrication
Non-woven mats were electrospun using PCL (Sigma-Aldrich, St. Louis, MO) with a
number-average molecular weight (Mn) of 114,000 ± 4,000 Da and a polydispersity index
(Mw/Mn) of 2.02 ± 0.04, as determined by gel permeation chromatography (Phenogel
Linear Column with 5-μm particles, Phenomenex, Torrance, CA; Differential Refractometer
410, Waters, Milford, MA, n=3) and a calibration curve generated from polystyrene
standards (Fluka, Switzerland). Briefly, a 14 wt% solution of PCL was prepared by
dissolving the polymer in a 5:1 volume ratio of chloroform to methanol. The polymer
solution was extruded at 25 ml/h through a 16 G needle, charged to 30 kV, towards a
grounded collecting plate 40 cm away. Fiber morphology was inspected using scanning
electron microscopy and determined to be 9.51±0.75 μm (n=32 fibers). Scaffolds were
punched from mats using a 1.5 mm dermal biopsy punch. Scaffolds approximately 1.6 mm
in thickness were used for this study.
After preparation, scaffolds were loaded into custom-designed polycarbonate blocks
designed to confine the cell suspension during seeding and sterilized by exposure to ethylene
oxide (Anderson Sterilizers, Haw River, NC) for 14 h. Scaffolds were then prewet by
soaking in a graded ethanol series, rinsed in phosphate buffered saline (PBS) three times,
and soaked in general medium (DMEM, 10% FBS, 1% PSF) for 72 h.
Cell isolation and culture
Bovine articular chondrocytes were isolated from the femoral chondyles of 7 to 10-day old
calves (Research 87, Boylston, MA) within 24 h of slaughter using previously described
methods [19]. Briefly, cartilage was isolated, minced to 1×1×1 mm pieces, washed with
PBS, and incubated in chondrocyte growth medium (DMEM, 10% FBS, 1% non-essential
amino acids, 50 μg/ml ascorbic acid, 46 μg/ml L-proline, 20 mM HEPES, 1% PSF)
supplemented with 2 mg/ml collagenase type II (Worthington biochemical corporation,
Lakewood, NJ) on a shaker table at 37°C for 16 h. Cells were isolated from 4 legs, pooled,
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aliquoted and cryopreserved in freezing medium (DMEM containing 20% FBS and 10%
dimethyl sulfoxide).
MSCs were isolated from the femora and tibiae of five 6-week old, male Lewis rats (150–
174 g; Harlan Laboratories, Indianapolis, IN) [20]. Care of the animals was provided in
accordance with the Rice University Institutional Animal Care and Use Committee.
Isolation was performed using previously described methods [20]. Briefly, after euthanasia,
the tibiae and femora were aseptically removed and the marrow was flushed from each bone
using 5 ml of general media. Marrow pellets were collected, broken up, and plated in 75-
cm2 tissue culture flasks. Medium was replaced after one day in order to remove the non-
adherent cell population. Cells were cultured for 5 days, after which they were lifted using
0.05% trypsin-EDTA, pooled, and cryopreserved in freezing medium for storage.
MSCs and chondrocytes were then thawed, plated, and expanded in chondrocyte growth
medium for 5 days. Cells were then lifted using 0.05% trypsin-EDTA, suspended in
chondrocyte growth medium. 30 μl of cell suspension, containing 40,000 cells, was pipetted
on top of each scaffold. Scaffolds were seeded with MSCs, chondrocytes, or a 1:3 mixture
chondroctyes and MSCs. Scaffolds were then incubated overnight to allow for cell
attachment. Empty scaffolds were also incubated for an additional night after prewetting in
chondrocyte growth medium. Prior to implantation scaffolds were removed from loading
blocks and rinsed in sterile PBS.
Animal surgeries
Animal surgeries were performed according to protocols approved by the Rice University
Institutional Animal Care and Use Committee, and NIH guidelines for the care and use of
laboratory animals (NIH Publication #85–23 Rev. 1985) were observed. Forty healthy male
Lewis rats (12-weeks old and weighing 300–350 g) were purchased from Harlan Labs
(Indianapolis, IN). Animals were anesthetized in an induction chamber with a 4%
isofluorane/oxygen gas mixture. Prior to surgery, each animal was given an intraperitoneal
injection of buprenorphine, an intraperitoneal injection of normal saline to account for fluid
losses during surgery, a subcutaneous injection of enrofloxacin as a prophylaxis against
infection during surgery, and a subcutaneous injection of bupivacaine along the intended
line of incision. Additionally, post-operatively each animal was given periodic
intraperitoneal injections of buprenorphine for post-operative analgesia.
During surgery, a lateral parapatellar longitudinal incision was made to expose the knee
joint. The synovial capsule was incised, and the trochlear groove was exposed after medial
luxation of the patella. With the knee maximally flexed, a defect (1.5 mm in diameter, and
1.5 mm in depth) was created in the center of the groove, using a dental drill. A 0.9 mm
diameter drill bit was first used to establish a 0.9 mm diameter defect. The defect was
irrigated and enlarged to 1.5 mm using a 1.5 mm drill bit, fashioned with a 1.5 mm stop to
ensure a defect of precisely 1.5 mm in depth is created. All debris was removed from the
defect with a curette and irrigation. Depending on the experimental group, the defect was
left untreated or a scaffold was press-fit into the defect with the appropriate cell population.
The patella was physically relocated, and the joint capsule and subcutaneous tissue was
closed with Vicryl 5–0 sutures. The skin was closed with Vicryl 4–0 sutures, which were
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removed after 1 week. After 12 weeks animals were euthanized via CO2 asphyxiation and
tissue surrounding the trochlear groove was removed en bloc. Samples were fixed in 10%
neutral buffered formalin for 72 h at room temperature. Following fixation samples were
stored in 70% ethanol.
μCT imaging and analysis
After tissue fixation the volume of mineralized bone in the defect was analyzed by
microcomputed tomography (Skyscan 1172 high-resolution micro-CT; Sky-scan) using
previously established methods [21]. To determine the volume of bone in the defect, a
region of interest 1.5 mm in diameter and 1.5 mm in thickness was selected by defining the
bottom region of the defect and measuring 1.5 mm toward the joint surface. The total
volume of mineralized bone was then calculated using thresholds 45 and 255.
Tissue processing
Samples were demineralized with EDTA and formic acid (Formical 2000; Decal
Corporation, Congers, NY) for 3 weeks on a shaker table at room temperature. Samples
were then prepared for crysosectioning by soaking in a solution of PBS with 15 wt%
sucrose, followed by PBS with 30% sucrose. Samples were then frozen in Histoprep
freezing medium at a controlled rate using chilled 2-methylbutane, and sectioned using a
cryotome (Leica CM 1850 UV; Leica Biosystems Nussloch GmbH, Germany). Longitudinal
sections 6 μm thick were mounted on glass slides. Sections were stained with Safranin O/
Fast Green and hematoxylin and eosin (H&E). Images were obtained using a light
microscope with a digital camera attachment (Axio Imager.Z2 equipped with AxioCam
MRc5; Carl Zeiss MicroImaging GmbH, Germany).
Histological scoring
Histological sections from the lateral and medial regions of each defect (total of 16 images
per group) were blindly scored by three independent evaluators (J.L., S.L., L.A.K.) based on
a modified version of a previously established scoring system for osteochondral tissue repair
in rabbits [22]. Sections were scored for the extent of cartilage repair based on 8 criteria, as
shown in Table 2.
Statistical analysis
A significance level of 0.05 was used for all statistical analysis. μCT data was analyzed by
one-way analysis of variance and Tukey’s multiple-comparision test. Data are reported as
means plus the standard deviation. Histological scores were analyzed using the Kruskal-
Wallis test followed by the Mann-Whitney-U test. Data are reported as the distribution of
scores for each parameter.
Results
μCT imaging and analysis
μCT analysis (Figure 1) found mineralized bone regeneration in the empty, blank, and MSC
samples that resulted in 28–35% of the defect site filled with new bone. No effect of the
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PCL scaffold or MSCs was observed on the total mineralized bone volume in the defect. In
the AC and CC samples, negligible mineralized bone growth was observed with a total bone
volume of only 0.75–1.0% of the defect site. Thus, significantly lower mineralized bone
volume was detected in the AC and CC samples compared to the empty, blank or MSC
samples.
Histological observation and scoring
Representative images of the histological sections from each group are shown in Figures 2–
6, while Figures 7 and 8 show the score distributions for each of the 8 parameters listed in
Table 2.
In general, the surface tissue of the empty samples contained large amounts of fibrous tissue
or fibrocartilage with only one sample containing any hyaline cartilage on the surface. The
vast majority of PCL and MSC samples only had a thin layer of fibrous tissue on the surface
of the defect. CC and AC samples often had hyaline-like cartilage on the edges or interior of
the defect with a portion of fibrous tissue in the center of the defect surface. In scoring the
morphology of new surface tissue, it was observed that the CC samples had higher quality
surface tissue compared to PCL and MSC samples.
When evaluating the morphology of the new cartilage tissue that formed in the defect site
(Fig. 7C) it was again seen that nearly all the empty, PCL, and MSC samples resulted in
either no cartilage growth in the defect site or cartilage that consisted almost exclusively of
fibrocartilage. However, a large portion of the CC and AC samples contained primarily
hyaline cartilage, rather then fibrocartilage, and while some had either no cartilage tissue or
primarily fibrocartilage, histological scoring still resulted in significantly higher quality
cartilage in the CC and AC samples then in the empty, PCL, and MSC samples.
Consistent with the evaluation of cartilage morphology, the evaluation of Safranin O
staining in the defects revealed more intense staining in the CC and AC samples compared
to the empty, PCL, and MSC groups. Little to no Safranin O staining was observed in the
PCL and MSC samples, and similarly 15 of 16 images analyzed from the empty samples
contained little to no Safranin O staining.
When evaluating the thickness of new cartilage tissue, fibrocartilage in the empty, PCL, and
MSC groups was generally found to be thinner than the neighboring cartilage thickness. In
the CC and AC samples, the new cartilage tissue was generally found to be thicker than the
neighboring tissue. Histological scoring found that CC and AC samples had significantly
thicker cartilage tissue then the empty PCL, and MSC samples.
When evaluating the density of chondrocytes in the new cartilage tissue, it was observed that
the AC samples scored significantly higher than the empty, PCL, and MSC samples, and the
CC samples had higher scores then the PCL samples. While a higher score would indicate a
more desirable outcome, and ideally a chondrocyte density most similar to the neighboring
cartilage, it should be noted that both the CC and AC groups had a large portion of samples
with a higher density of chondrocytes compared to the surrounding tissue.
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Evaluating the distribution of chondrocytes in the tissue, it was observed that the empty,
PCL, and MSC samples mostly consisted of individual or disorganized cells, whereas CC
and AC samples primarily consisted of clustered chondrocytes. Thus, the CC and AC groups
scored significantly higher in chondrocyte distribution compared to the empty, PCL, and
MSC samples.
When evaluating the regularity of the joint surface as well as the chondrocyte and GAG
content of the adjacent cartilage, it was observed that the AC samples had significantly
worse joint regularity than the empty, PCL, or MSC samples and the CC samples had worse
regularity than the PCL samples. However, the CC samples were seen to have higher quality
adjacent cartilage than the empty, PCL, and MSC samples.
Consistent with the results of μCT analysis, significant bone ingrowth was observed
throughout the empty, PCL, and MSC samples (Fig. 2–4). Conversely, negligible bone
growth was observed in the CC and AC samples. Instead, the scaffold was primarily
surrounded by fibrous tissue (Fig. 5E and 6E) with transitional tissue (Fig. 5D and 6D)[23]
observed in the interior of the scaffold. The ingrown tissue had no Safranin O staining, and
contained cells that were either oval or spheroid in shape with some present in lacunae (Fig.
6D).
Discussion
Clinically, autologous chondrocytes have long been recognized for their ability to repair
chondral defects when transplanted in vivo [3]. Currently, the ACI procedure involves initial
biopsy of autologous cartilage for the isolation of articular chondrocytes, expansion of cells
in vitro, and implantation of expanded cells into the defect, which is sealed by a layer of
periosteum sutured over top [1]. While the technique is widely used in the clinic, the use of
autologous chondrocytes presents several challenges to the long-term success of the
treatment. Isolating large numbers of chondrocytes from healthy cartilage not only leads to
donor site morbidity, but also is a challenge due to the relatively low density of
chondrocytes in cartilage tissue [4]. Furthermore, rapid phenotypic changes are seen during
in vitro expansion of chondrocytes, which leads to a cell population with a more fibroblastic
phenotype than healthy articular chondrocytes [6]. Co-cultures of articular chondrocytes and
MSCs have previously been shown, through in vitro analysis, to be able to provide several
potential means to overcome some of the challenges posed by the use of articular
chondrocytes alone [8, 9, 11].
Co-culture of articular chondrocytes and MSCs have been thoroughly investigated in vitro,
and the utility of this approach has generally been shown to be the ability to use up to 75%
fewer chondrocytes, while still achieving equal or greater levels of chondrogenesis as
cultures containing 100% chondrocytes [9, 11]. While numerous studies have characterized
these cultures in vitro, they have not been investigated for their ability to regenerate cartilage
in an orthotopic site in vivo. The objective of the present study was to evaluate the ability of
co-cultures of chondrocytes and MSCs to repair articular cartilage in a rat osteochondral
defect when implanted with an electrospun polymer scaffold. We hypothesized that such co-
cultures would lead to equal or greater cartilage repair, while utilizing significantly fewer
Dahlin et al. Page 7
Biomaterials. Author manuscript; available in PMC 2015 August 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
chondrocytes, than chondrocytes alone. For consistency with previous in vitro studies [8–
11], we chose to use a 1:3 ratio of chondrocytes-to-MSCs seeded on electrospun PCL
scaffolds. The animal model chosen for this study was a previously established
osteochondral defect in the rat trochlear groove [24, 25]. Due to the impracticality of
isolating rat cartilage, bovine articular chondrocytes were used for this study. Even using
xenogeneic chondrocytes in this model, we observed no evidence of an immune response to
the bovine cells in either the AC or CC groups. In addition we observed hyaline-like
cartilage formation in these samples, demonstrating that the implanted cells were beneficial
to the tissue repair. Several other studies have demonstrated similar success with xenogenic
chondrocytes in chondral and osteochondral defects without signs of an immune response
[26, 27].
As hypothesized, chondrocytes and co-cultures of chondrocytes and MSCs led to enhanced
cartilage repair in vivo, as primarily characterized by repair tissue that consisted of thicker
hyaline-like cartilage with more intense Safranin O staining. Conversely, new cartilage
formed in the empty, PCL, and MSC samples primarily consisted of fibrocartilage, a
common form of repair tissue composed primarily of collagen type I and low amounts of
type II collagen and proteoglycans [28]. Due to the inferior mechanical properties of this
tissue composition, compared to hyaline cartilage, the fibrocartilage is not expected to
withstand long-term mechanical loading and may deteriorate over time [2]. Consistent with
this tissue characterization, the CC and AC samples were found to have more intense
Safranin O staining than the other samples, indicative of higher proteoglycan content and a
more hyaline-like tissue [29]. Furthermore, new cartilage formed in the CC and AC samples
was not only of a superior morphology but was found to be much thicker than new cartilage
formed in the empty, PCL, and MSC samples. This result is correlated to the ability of the
different treatments to form cartilage but may also be due to deterioration of repair cartilage
prior to twelve weeks in the empty, PCL, and MSC samples. Based on the histological
scoring, the adjacent cartilage of the empty, PCL, and MSC samples showed signs of
degenerative changes, relative to the CC samples, providing evidence of the likelihood of
past or future deterioration of the repair tissue. Investigation of additional time points in
future studies would likely shed light on the long-term stability of this tissue. Additionally,
the distribution of cells in the CC and AC samples was found to be more similar to native
cartilage, again indicating an improved healing response compared to empty, PCL, and MSC
samples. Overall, it was observed that the CC and AC samples led to the formation of new
cartilage tissue with a higher quality composition and structure compared to the empty, PCL,
and MSC samples. The quality of this tissue is more similar to native hyaline cartilage and
would be expected to be a more functional and durable tissue compared to the fibrocartilage
seen in the other samples.
While the newly formed cartilage of the CC and AC samples was in many ways
significantly higher quality repair tissue than the empty, PCL, and MSC samples, the surface
regularity of the AC samples was worse than all groups other than CC. This may be a result
of the large amount of cartilage formation that did not integrate well with the surrounding
tissue: a significant challenge in cartilage repair [2]. Alternatively, the poor surface
regularity could be a result of the lack of bone formation in the subchondral region, and thus
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lack of stability of the newly formed tissue [30, 31]. Furthermore, in many instances, the
new cartilage tissue in the CC and AC samples had a slight concave structure with the center
filled with fibrous tissue. This indentation may be further evidence of a lack of underlying
structural support in these samples. The drastic difference in bone and cartilage healing that
was observed in these samples is quite remarkable when the impact of the subchondral bone
in cartilage regeneration is considered. It is well established that the healing of the
subchondral bone is crucial to both the regeneration and stability of articular cartilage [32–
34], so the stark improvement in cartilage repair seen in samples with no subchondral bone
healing at 12 weeks was a significant outcome that demonstrates the robust ability of the CC
and AC treatments to stimulate cartilage repair.
Transitional tissue has been described as a tissue that is comprised of ovoid and spherical
cells, present with or without lacunae. This tissue characterization encompasses tissues that
range from fibrous tissue to hyaline cartilage and includes, but is not limited to,
fibrocartilage [23, 35]. Most transitional tissue is of a higher regenerative quality than
fibrous tissue, but a lower quality than fibrocartilage [36]. Studies evaluating the quality of
new tissue seen in repair procedures have often observed the formation of transitional tissue
after the deterioration of hyaline tissue or the presence of transitional tissue without earlier
evidence of hyaline cartilage [37–39]. In the present study, transitional tissue was observed
to be the primary tissue type that grew into the subchondral region of the CC and AC
samples. Without earlier time points, we are unable to determine the initial morphology of
the ingrown tissue; however it is possible that this tissue was of a higher quality cartilage
repair tissue that deteriorated to its present state. Likewise, it is possible that this tissue
would eventually remodel and bone ingrowth would occur into the subchondral regions of
the scaffold. However, future studies should investigate the use of a bilayered treatment
method that could accelerate the bone healing in the subchondral region of the CC and AC
samples. The presence of subchondral support may further enhance the cartilage repair [32,
33].
Interestingly, when seeded on PCL scaffolds, MSCs had no measurable effect on either
cartilage healing or mineralized bone volume compared to PCL scaffolds alone. While
numerous studies have demonstrated enhanced cartilage [40, 41] repair with the delivery of
MSCs, other work has observed no effect of delivered MSCs on cartilage repair [31].
Potentially, the method of cell delivery in this study may have not allowed for condensation
of the MSCs. Other studies delivering MSCs in osteochondral defects have been capable of
achieving MSC condensation, which is known to enhance chondrogenesis [40].
Furthermore, the delivery of undifferentiated MSCs may not have provided the cells with
enough chondrogenic stimuli to lead to cartilage formation. Possibly the use of
chondrogenically pre-differentiated MSCs may have seen improved chondrogenesis [42].
The results of the present study indicate the potential for the use of co-cultures of articular
chondrocytes and MSCs to be used for in vivo repair of articular cartilage defects. The
number of cells seeded onto the PCL scaffolds in this study was a density of cells that is
approximately three times lower then the density reported for use in clinical ACI procedures
[3]. However, the use of a polymer scaffold makes the current approach more similar to
matrix-associated ACI procedures, which have been demonstrated to be capable of success
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with approximately half the number of cells needed for first generation ACI procedures [43].
Furthermore, these results may indicate the mechanism for success of experimental
procedures investigating the combination of ACI with microfracture [23]. Therein it was
observed that the combination of ACI with microfracture led to improved cartilage repair
compared to ACI alone. Based on the results of the present study, one may postulate that the
combination of bone marrow progenitor cells with ACI led to enhanced repair in a similar
manner as demonstrated for the effect of co-cultures of MSCs and chondrocytes. Regardless,
the results here demonstrate that co-implantation of MSCs with chondrocytes can reduce the
total number of chondrocytes needed for implantation when implanted with a total density of
cells in the same range as ACI or matrix-associated ACI procedures. The outcome of matrix
associated ACI procedures was shown to be dependent on in vitro culture conditions, such
as the cell passage number [14], and thus the addition of MSCs to chondrocytes may allow
for the use of lower passaged chondrocytes and thus improved outcomes.
Conclusions
This study demonstrated the ability of co-cultures of articular chondrocytes and MSCs to
repair cartilage defects in the rat trochlear groove defect. These results have important
implications for cartilage tissue engineering, as they demonstrate that such co-cultures could
be used to reduce the total number of chondrocytes needed for cartilage repair, while still
achieving an equivalent level of cartilage repair.
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Figure 1.
Percent of defect volume filled with mineralized bone, as determined by microcomputed
tomography. Data are reported as means + standard deviation for n=8 animals. Groups not
connected by the same letter are significantly different (p<0.05).
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Figure 2.
Representative histological sections of tissue formation after 12 weeks in untreated defects
in the rat trochlear groove (empty). Sections were stained with H&E (A, C, D, and E) and
Safranin O/Fast Green (B). Scale bars in A and B each represent 250 μm, and scale bar in C
represents 50 μm in C, D, and E. A and B show mostly fibrous tissue with limited
fibrocartilage in the chondral region and bone growth in the subchondral space. C, D, and E
show high magnification images of the chondral and subchondral regions.
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Figure 3.
Representative histological sections of tissue formation after 12 weeks of implantation of
electrospun PCL scaffolds (PCL). Sections were stained with H&E (A, C, D, and E) and
Safranin O/Fast Green (B). Scale bars in A and B each represent 250 μm, and scale bar in C
represents 50 μm in C, D, and E. A and B show mostly fibrous tissue with limited
fibrocartilage in the chondral region and new bone growth into the nondegraded PCL
scaffold. Round, unstained regions of approximately 10 μm show fibers comprising the PCL
scaffold. C, D, and E show high magnification images of the chondral and subchondral
regions.
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Figure 4.
Representative histological sections of tissue formation after 12 weeks of implantation of
electrospun PCL scaffolds seeded with rat MSCs (MSC). Sections were stained with H&E
(A, C, D, and E) and Safranin O/Fast Green (B). Scale bars in A and B each represent 250
μm, and scale bar in C represents 50 μm in C, D, and E. A and B show mostly fibrous tissue
with limited fibrocartilage in the chondral region and new bone growth into the nondegraded
PCL scaffold. Round, unstained regions of approximately 10 μm show fibers comprising the
PCL scaffold. C, D, and E show high magnification images of the chondral and subchondral
regions.
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Figure 5.
Representative histological sections of tissue formation after 12 weeks of electrospun PCL
scaffolds seeded with a co-culture of rat MSCs and bovine articular chondrocytes (CC).
Sections were stained with H&E (A, C, D, and E) and Safranin O/Fast Green (B). Scale bars
in A and B each represent 250 μm, and scale bar in C represents 50 μm in C, D, and E. A
and B show thick regions of hyaline-like cartilage with some fibrocartilage and fibrous
tissue in the chondral region. The subchondral region is composed mainly of transitional and
fibrous tissue. Round, unstained regions of approximately 10 μm show fibers comprising the
PCL scaffold. C, D, and E show high magnification images of the chondral and subchondral
regions.
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Figure 6.
Representative histological sections of tissue formation after 12 weeks of electrospun PCL
scaffolds seeded with bovine articular chondrocytes (AC). Sections were stained with H&E
(A, C, D, and E) and Safranin O/Fast Green (B). Scale bars in A and B each represent 250
μm, and scale bar in C represents 50 μm in C, D, and E. A and B show thick regions of
hyaline-like cartilage with some fibrocartilage and fibrous tissue in the chondral region. The
subchondral region is composed mainly of transitional and fibrous tissue. Round, unstained
regions of approximately 10 μm show fibers comprising the PCL scaffold. C, D, and E show
high magnification images of the chondral and subchondral regions.
Dahlin et al. Page 18
Biomaterials. Author manuscript; available in PMC 2015 August 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 7.
Histological score distribution for the (A) morphology of new surface tissue, (B) Safranin O
staining, (C) morphology of new cartilage, and (D) thickness of new cartilage. Specific
scoring criteria for each category is listed in Table 2. Groups not connected by the same
letter shown on top of the bars are significantly different (p<0.05).
Dahlin et al. Page 19
Biomaterials. Author manuscript; available in PMC 2015 August 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 8.
Histological score distribution for the (A) chondrocyte cellularity, (B) chondrocyte
distribution, (C) joint surface regularity, and (D) chondrocyte and GAG content of adjacent
cartilage. Specific scoring criteria for each category is listed in Table 2. Groups not
connected by the same letter shown on top of the bars are significantly different (p<0.05).
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Table 2
Histological scoring system for the evaluation of cartilage repair in rat osteochondral defects based off of a
modified version of a previously established scoring system for rabbit osteochondral tissue repair (22)
Morphology of New Surface Tissue
Exclusively AC 4
Mainly hyaline cartilage 3
Fibrocartilage (spherical morphology in >75% of cells) 2
Mostly fibrous tissue (spherical morphology in <75% cells) 1
No tissue 0
Morphology of New Cartilage Tissue
Exclusively AC 3
Mainly hyaline cartilage 2
Fibrocartilage 1
Only fibrous tissue/ No tissue 0
Thickness of New Cartilage
Similar to surrounding cartilage 3
Greater than surrounding cartilage 2
Less than surrounding cartilage 1
No cartilage 0
Joint Surface Regularity
Smooth, intact surface 3
Surface fissures (<25% new surface thickness) 2
Deep fissures (25–99% new surface thickness) 1
Complete disruption of the new surface 0
Chondrocyte Distribution
Columnar 3
Mixed columnar-clusters 2
Clusters 1
Individual or disorganized cells 0
Chondrocyte Cellularity
Similar number of chondrocytes 3
More chondrocytes 2
Fewer chondrocytes 1
No chondrocytes 0
Safranin O Staining
Similar staining intensity 4
Stronger staining intensity 3
Moderate staining intensity 2
Poor staining intensity 1
Little or no staining intensity 0
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Chondrocyte and GAG Content of Adjacent Cartilage
Normal cellularity with normal GAG content 3
Normal cellularity with moderate GAG content 2
Clearly less cells with poor GAG content 1
Few cells with little or no GAGs or no cartilage 0
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